Acutaas Chemicals · NSE: ACUTAAS · BSE: 543349
Q4 FY25 results · Jan–Mar 2025
Acutaas Chemicals reported revenue from operations of ₹308.48 crore (up 37.1% from Q4 FY24) and net profit of ₹62.72 crore (up 144.2% from Q4 FY24) for Q4 FY25 (Jan–Mar 2025), on a consolidated basis.
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 308.48 | 224.96 | +37.1% | 274.99 | +12.2% |
| Other income | 5.78 | 1.34 | +330.2% | 1.67 | +245.8% |
| Total income | 314.26 | 226.30 | +38.9% | 276.66 | +13.6% |
| Profit before tax | 82.83 | 37.20 | +122.7% | 63.33 | +30.8% |
| Net profit for the period | 62.72 | 25.68 | +144.2% | 45.45 | +38.0% |
| Attributable to shareholders of the company | 62.48 | 25.15 | +148.4% | 44.95 | +39.0% |
| EPS, basic (₹) | 7.80 | 6.86 | not comparable | 11.35 | not comparable |
| Net margin (%) | 20.3 | 11.4 | 16.5 |
| Item | Q4 FY25 | Q4 FY24 | YoY | Q3 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 304.16 | 219.94 | +38.3% | 270.94 | +12.3% |
| Other income | 5.69 | 8.55 | −33.4% | 2.17 | +162.8% |
| Total income | 309.86 | 228.49 | +35.6% | 273.11 | +13.5% |
| Profit before tax | 82.81 | 42.29 | +95.8% | 62.54 | +32.4% |
| Net profit for the period | 62.85 | 32.08 | +95.9% | 45.31 | +38.7% |
| EPS, basic (₹) | 7.84 | 8.75 | not comparable | 11.31 | not comparable |
| Net margin (%) | 20.7 | 14.6 | 16.7 |
Consolidated
- Filed with BSE
- 02 May 2025, 17:44 IST
- Board meeting
- 02 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 02 May 2025, 17:44 IST
- Board meeting
- 02 May 2025
- Period
- 01 Jan 2025 to 31 Mar 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE